nfr-logonfr-logo
PROSJEKTBANKEN
Bytt til Norsk språk
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

PES2020-Prosj.etabl.støtte H2020

Development of a novel drug for the treatment of patients with glycolytic cancers

Arctic Pharma´s overall goal is to bring a new class of cancer medicine to the marked which targets the energy metabolism of many aggressive cancer types. In particular, Arctic Pharma AS has developed small molecular inhibitors that are designed to target the molecule lactate dehydrogenase (LDH),...

Tildelt: kr 99 999

Prosjektperiode: 2019-2019

Sted: Oslo

FRIMEDBIO-Fri prosj.st. med.,helse,biol

International symposium on Personalized Cancer Care: From risk prediction, early diagnosis, progression, and therapy.

International Symposium on Personalized Cancer Care; What have we achieved since 2012 in risk prediction, early diagnosis, progression, and therapy? Oslo, May18-20, 2016, Holmenkollen Park Hotel Conference Center Opening keynote on P4 and Cancer: Leroy Hood, Institute for Systems Biology,...

Tildelt: kr 0,25 mill.

Prosjektperiode: 2016-2016

Sted: Oslo

FRIMED-Klinisk medisin og folkehelse

International Confernce on discovery based translational research

Following very successful meetings in recent years, the European Association for Cancer Research (EACR) will be staging its biennial conference EACR 21 in Oslo to discuss the latest developments in cancer research and science. The conference will be broad and balanced, and will include Gene Expr...

Tildelt: kr 0,25 mill.

Prosjektperiode: 2010-2011

Sted: Oslo

KREFT-Offentlig kreftprogram

Understanding Breast Cancer Genomics; Towards combined molecular profiles for better diagnosis and treatment

We seek to reach a more fundamental understanding of the biological dynamics of breast cancer. High-throughput molecular data at multiple levels (eg DNA, mRNA, miRNA and protein level) have become available on increasing numbers of patients, and various m olecular profiles have been associated wi...

Tildelt: kr 10,5 mill.

Prosjektperiode: 2009-2012

Sted: Oslo

FUGE-Funksjonell genomforskn.i Norg

The Systems Biology of Breast Cancer

Systems Biology of Breast Cancer creates a world-class cancer research team, working systematically towards understanding of the biological dynamics of breast cancer. Breast cancer is a genetic disease; breast tumor genomes are dynamic and tumors are com plex systems shaped by gene aberrations, ...

Tildelt: kr 9,0 mill.

Prosjektperiode: 2006-2010

Sted: Oslo

FUGE-Funksjonell genomforskn.i Norg

Mutant p53 as a target for improved cancer treatment

This project is a multi-disciplinary approach to explore and exploit the contribution of mutp53 to cancer. We will investigate in depth the molecular properties of mutp53: structural studies will pinpoint the changes that particular mutations inflict on t he structure of p53, and allow the classi...

Tildelt: kr 0,59 mill.

Prosjektperiode: 2004-2004

Sted: Ukjent Fylke

GRUSYK-Grunnleggende sykdomsmekanisme

Molecular Genetic Studies of Breast Cancer. Identification of genotypes and gene expression profiles contributing to elevated cancer risk,..

...

Tildelt: kr 10,0 mill.

Prosjektperiode: 2003-2007

Sted: Oslo

PASIENT-Pas.nær klin.forskn.o.alt.med.

Molecular studies of tumour response and tissue sensitivity to radiation therapy among patients with breast cancer.

Brystkreft er en stadig økende kreftsykdom, og ca 1 av 12 kvinner i Norge vil utvikle sykdommen i løpet av sin livstid. Behandlingsstrategien avhenger blant annet av stadium, alder (menopausal status) og hormonreseptorstatus. Strålebehandling utgjør en st adig økende del av behandlingsopplegget. ...

Tildelt: kr 0,79 mill.

Prosjektperiode: 2003-2004

Sted: Oslo

1